How Effective Is Opdivo in Treating Esophageal Cancer?
Nivolumab, popularly known as Opdivo, marks a significant advancement in esophageal cancer treatment, providing hope for patients who have previously exhausted traditional therapies. Its role in enhancing disease-free survival rates, especially in combination with other therapies, is supported by pivotal clinical trials like CheckMate 577. With FDA approval, Opdivo offers a broadened therapeutic scope, embracing […]
3 minute read